MedTrace Logo

Early Identification of Clinical Deterioration Using a Wearable Monitoring Device

NCT04220359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2021-05-25

No results posted yet for this study

Summary

This study aims to provide myriad of physiological parameters in patients admitted in an internal medicine department, and which are defined as being in an increased risk of clinical deterioration within the first 72-hours after admission. The investigators will also conduct a retrospective comparison between physiological changes in patients who did deteriorate to those who did not. This will form the basis for the development of an algorithm for early prediction and warning of physiological and clinical deterioration during the first 72-hours of admission.

Conditions

  • Clinical Deterioration
  • Hemodynamic Instability

Interventions

DEVICE

non-invasive monitoring

Prospective monitoring with retrospective big-data analysis

Sponsors & Collaborators

  • Sheba Medical Center

    collaborator OTHER_GOV

  • Biobeat Technologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Gad Segal, MD · The Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2021-04-15
Completion
2021-04-30
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04220359 on ClinicalTrials.gov